Effectiveness and safety of nab-paclitaxel in metastatic breast cancer

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HPS-014
• By: GARCíA GIMéNEZ, Ignacio ()
• Co-author(s): Mrs Isabel María Carrión Madroñal (Hospital Universitario Juan Ramón Jiménez, Huelva;, Spain)
  Olalla Montero Pérez, Pharmacy Department (Hospital Universitario Juan Ramón Jiménez, Huelva;, Spain)
  Ignacio García Giménez, Pharmacy Department (Hospital Universitario Juan Ramón Jiménez, Huelva;, Spain)
  María Teresa Garrido Martínez, Pharmacy Department (Hospital Universitario Juan Ramón Jiménez, Huelva;, Spain)
  
• Abstract:

  KEYWORDS: breast cancer, effectiveness, nab-paclitaxel, safety.
  
  BACKGROUND:
  Pivotal phase III randomized controlled trials have demonstrated promising efficacy of nab-paclitaxel for the treatment of metastatic breast cancer. However, trial results might have limited external validity in daily practice so real-life studies are commonly performed..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login